A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
高通量药物筛选确定木犀草素是病理性心脏肥大和心力衰竭的治疗候选药物
期刊:Frontiers in Cardiovascular Medicine
影响因子:2.8
doi:10.3389/fcvm.2023.1130635
Zhenya Wang, Wei Shi, Taibo Wu, Tian Peng, Xiaoming Wang, Shuaiyang Liu, Zifeng Yang, Jia Wang, Peng-Long Li, Ruifeng Tian, Ying Hong, Hailong Yang, Lan Bai, Yufeng Hu, Xu Cheng, Hongliang Li, Xiao-Jing Zhang, Zhi-Gang She